Yoshiki Takada

Phase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Mitomycin, Vindesine, and Cisplatin in Unresectable Stage III Non–Small-Cell Lung Cancer

Kiyoyuki Furuse, Masahiro Fukuoka, Masaaki Kawahara et al. · Journal of Clinical Oncology · 1999 · 1.5K citations

Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer

Kayoko Tsujino, Saeko Hirota, Masahiro Endo et al. · International Journal of Radiation Oncology*Biology*Physics · 2002 · 357 citations

Nuclear Medicine, Medical Imaging, Dose-volume Histogram Parameters +11

Phase II study of amrubicin in previously untreated patients with extensive-disease small cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) study

Takashi Yana, Shunichi Negoro, Minoru Takada et al. · Investigational New Drugs · 2006 · 111 citations

Medicine, Pathology, Phase Ii Study +7

Dosimetric predictors of radiation esophagitis in patients treated for non-small-cell lung cancer with carboplatin/paclitaxel/radiotherapy

Saeko Hirota, Kayoko Tsujino, Masahiro Endo et al. · International Journal of Radiation Oncology*Biology*Physics · 2001 · 71 citations

Non-small-cell Lung Cancer, Radiation Therapy, Medicine +9

Radiation pneumonitis following concurrent accelerated hyperfractionated radiotherapy and chemotherapy for limited-stage small-cell lung cancer: Dose–volume histogram analysis and comparison with conventional chemoradiation

Kayoko Tsujino, Saeko Hirota, Yoshikazu Kotani et al. · International Journal of Radiation Oncology*Biology*Physics · 2005 · 63 citations

Hyperfractionated Radiotherapy, Radiation Medicine, Health Sciences +9